Ken Griffin Exscientia PLC Put Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$4.26 - $6.0 $21,300 - $30,000	5,000 Added 7.15%	74,900 $365,000
Q2 2024 Aug 14, 2024	BUY	$3.99 - $6.04 $183,141 - $277,236	45,900 Added 191.25%	69,900 $356,000
Q1 2024 May 15, 2024	SELL	$5.3 - $7.51 $2,120 - $3,004	-400 Reduced 1.64%	24,000 $137,000
Q4 2023 Feb 14, 2024	BUY	$4.35 - $6.88 $54,809 - $86,688	12,600 Added 106.78%	24,400 $156,000
Q3 2023 Nov 14, 2023	SELL	$4.52 - $8.9 $19,887 - $39,160	-4,400 Reduced 27.16%	11,800 $53,000
Q2 2023 Aug 14, 2023	SELL	$4.79 - $8.3 $15,807 - $27,390	-3,300 Reduced 16.92%	16,200 $95,000
Q1 2023 May 15, 2023	BUY	$5.3 - $10.93 $76,320 - $157,392	14,400 Added 282.35%	19,500 $103,000
Q4 2022 Feb 14, 2023	BUY	$4.1 - $8.94 $20,910 - $45,594	5,100 New	5,100 $27,000

100

33.5M

500

189K

Ticker EXAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 122,461,000
Market Cap $574M
Description
Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on s...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.